Enhanced ROS production in oncogenically transformed cells potentiates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase activation and sensitization to genotoxic stress

Molecular and Cellular Biology

Volumn 21, Issue 20, 2001, Pages 6913-6926

  Benhar, M ^a   Dalyot, I ^a   Engelberg, D ^a   Levitzki, A ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CISPLATIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; ONCOPROTEIN; RAS PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN;

ARTICLE; CELL DEATH; CONTROLLED STUDY; ENZYME ACTIVATION; GENE OVEREXPRESSION; GENOTOXICITY; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; MITOCHONDRIAL RESPIRATION; PRIORITY JOURNAL; RESPIRATORY CHAIN; SENSITIZATION; STRESS;

3T3 CELLS; ANIMALS; ANISOMYCIN; ANTINEOPLASTIC AGENTS; APOPTOSIS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL LINE, TRANSFORMED; CELL SURVIVAL; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; FLOW CYTOMETRY; FLUORESCEINS; FLUORESCENT DYES; HUMANS; IMMUNOBLOTTING; IN SITU NICK-END LABELING; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE KINASE 3; MAP KINASE KINASE 6; MICE; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PLASMIDS; PROTEIN SYNTHESIS INHIBITORS; PROTEIN-TYROSINE KINASES; REACTIVE OXYGEN SPECIES; RECEPTOR, EPIDERMAL GROWTH FACTOR; STRESS; TIME FACTORS; TRANSFECTION;

EID: 0034806972     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.21.20.6913-6926.2001     Document Type: Article

References (59)

1. Role of redox potential and reactive oxygen species in stress signaling
2. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo
3. p185c-erbB-2 signal enhances cisplatin-induced cytotoxicity in human breast carcinoma cells: Association between an oncogenic receptor tyrosine kinase and drug-induced DNA repair
4. Oncogenic transformation alters cisplatin-induced apoptosis in rat embryo fibroblasts
5. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine
6. Fas- or ceramide-induced apoptosis is mediated by a Rac1-regulated activation of Jun N-terminal kinase/p38 kinases and GADD153
7. c-Jun NH2-terminal kinase regulation of the apoptotic response of small cell lung cancer cells to ultraviolet radiation
8. 1251-Labeled human epidermal growth factor. Binding, internalization, and degradation in human fibroblasts
9. Inhibition of UV irradiation-induced oxidative stress and apoptotic biochemical changes in human epidermal carcinoma A431 cells by genistein
10. Stabilization of interleukin-2 mRNA by the c-Jun NH2-terminal kinase pathway
11. Oncogenic transformation potentiates apoptosis. S-phase arrest and stress-kinase activation by etoposide
12. Tumor promoter arsenite activates extracellular signal-regulated kinase through a signaling pathway mediated by epidermal growth factor receptor and Shc
13. The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and gamma radiation. Duration of JNK activation may determine cell death and proliferation
14. ASK1 mediates apoptotic cell death induced by genotoxic stress
15. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1
16. Arachidonic acid activates c-jun N-terminal kinase through NADPH oxidase in rabbit proximal tubular epithelial cells
17. Inhibition of cell growth by lovastatin is independent of ras function
18. E1A signaling to p53 involves the p19(ARF) tumor suppressor
19. Abrogation of cisplatin-induced programmed cell death in human breast cancer cells by epidermal growth factor antisense RNA
20. Mitochondrial contributions to cancer cell physiology: Redox balance, cell cycle, and drug resistance
21. A synthetic inhibitor of the mitogen-activated protein kinase cascade
22. A matter of life and cell death
23. Dual effect of normal and stimulated macrophages and their conditioned media on target cell proliferation
24. Mitochondria and apoptosis
25. Redox regulation of signal transduction in mammalian cells
26. Kinetic parameters of the protein tyrosine kinase activity of EGF-receptor mutants with individually altered autophosphorylation sites
27. Signal transduction by the c-Jun N-terminal kinase (JNK) - From inflammation to development
28. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts
29. Reactive oxygen species and programmed cell death
30. Redox regulation of cellular signalling
31. Mitogen-activated protein kinase cascades as regulators of stress responses
32. Enhancement of chemotherapeutic agents induced-apoptosis associated with activation of c-Jun N-terminal kinase 1 and caspase 3 (CPP32) in bax-transfected gastric cancer cells
33. Sounding the alarm: Protein kinase cascades activated by stress and inflammation
34. The stress-activated protein kinase subfamily of c-Jun kinases
35. HER2 cytoplasmic domain generates normal mitogenic and transforming signals in a chimeric receptor
36. Tyrosine kinase inhibition: An approach to drug development
37. Signal transduction through MAP kinase cascades
38. Reactive oxygen species mediate cytokine activation of c-Jun NH2-terminal kinases
39. Expression of mitogen-activated protein kinase phosphatase-1 in the early phases of human epithelial carcinogenesis
40. Mitogen-activated protein kinase phosphatase 1 is overexpressed in prostate cancers and is inversely related to apoptosis
41. Epidermal growth factor receptor family and chemosensitization
42. Regulation and function of the JNK subgroup of MAP kinases
43. Role of reactive oxygen species in cis-dichlorodiammineplatinum-induced cytotoxicity on bladder cancer cells
44. Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteases
45. Epidermal-growth-factor-dependent activation of the src-family kinases
46. Stress-activated protein kinases (JNK and p38/HOG) are essential for vascular endothelial growth factor mRNA stability
47. Pro-inflammatory, cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine
48. Mechanisms of apoptosis avoidance in cancer
49. Mitogen-activated protein kinase pathways
50. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway
51. Persistent oxidative stress in cancer
52. p38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy
53. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis
54. The cellular response to oxidative stress: Influences of mitogen-activated protein kinase signalling pathways on cell survival
55. The level of intracellular glutathione is a key regulator for the induction of stress-activated signal transduction pathways including Jun N-terminal protein kinases and p38 kinase by alkylating agents
56. The decrease of mitochondrial NADH dehydrogenase and drug induced apoptosis in doxorubicin resistant A431 cells
57. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis
58. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization
59. Linearization of the Bradford protein assay increases its sensitivity: Theoretical and experimental studies